digestive enzymes with glp-1 While on GLP-1: Safety and Evidence What Does GLP-1 Stand For?
Description
Completely avoiding weight regain is difficult without intervention, but maintaining most of your loss is achievable with a structured transition
Recently, administration of a long-acting GIP receptor agonist in humans, reduced GLP-1 analogue related gastrointestinal side effects, including nausea and vomiting (106)
However, therapeutic effects begin to diminish sooner, with blood glucose levels typically rising within 12 weeks of discontinuation
only a licensed healthcare professional can determine whether GLP-1 therapy is appropriate for you
These trials demonstrated significant weight loss in patients treated with Mounjaro compared to placebo
Options include bioelectrical impedance scales, DEXA scans, or a simple tape measure to assess nonscale changes
